NO982875L - Tablett med hurtig frigivelse omfattende tolfenaminsyre eller et farmasöytisk akseptabelt salt av denne - Google Patents

Tablett med hurtig frigivelse omfattende tolfenaminsyre eller et farmasöytisk akseptabelt salt av denne

Info

Publication number
NO982875L
NO982875L NO982875A NO982875A NO982875L NO 982875 L NO982875 L NO 982875L NO 982875 A NO982875 A NO 982875A NO 982875 A NO982875 A NO 982875A NO 982875 L NO982875 L NO 982875L
Authority
NO
Norway
Prior art keywords
rapid
pharmaceutically acceptable
acceptable salt
release tablet
tolfenamic acid
Prior art date
Application number
NO982875A
Other languages
English (en)
Other versions
NO316869B1 (no
NO982875D0 (no
Inventor
Knud Erik Gebhard-Hansen
Karen Bjoernsdottir
Lars Hedevang Christensen
Soeren Bols Pedersen
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO982875D0 publication Critical patent/NO982875D0/no
Publication of NO982875L publication Critical patent/NO982875L/no
Publication of NO316869B1 publication Critical patent/NO316869B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19982875A 1995-12-20 1998-06-19 Tablett med hurtig frigivelse omfattende tolfenamsyre eller et farmasoytisk akseptabelt salt av denne, fremgangsmate for fremstilling derav samt anvendelse for fremstilling derav NO316869B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK144895 1995-12-20
PCT/DK1996/000548 WO1997022340A1 (en) 1995-12-20 1996-12-19 Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof

Publications (3)

Publication Number Publication Date
NO982875D0 NO982875D0 (no) 1998-06-19
NO982875L true NO982875L (no) 1998-08-19
NO316869B1 NO316869B1 (no) 2004-06-07

Family

ID=8104933

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19982875A NO316869B1 (no) 1995-12-20 1998-06-19 Tablett med hurtig frigivelse omfattende tolfenamsyre eller et farmasoytisk akseptabelt salt av denne, fremgangsmate for fremstilling derav samt anvendelse for fremstilling derav

Country Status (27)

Country Link
US (1) US6036975A (no)
EP (1) EP0869783B1 (no)
JP (1) JP2000515489A (no)
CN (1) CN1147295C (no)
AR (1) AR004395A1 (no)
AT (1) ATE234085T1 (no)
AU (1) AU1190097A (no)
BR (1) BR9612057A (no)
CA (1) CA2244396A1 (no)
CZ (1) CZ293422B6 (no)
DE (1) DE69626676T2 (no)
DK (1) DK0869783T3 (no)
EE (1) EE9800186A (no)
ES (1) ES2191781T3 (no)
HR (1) HRP960598A2 (no)
HU (1) HU224030B1 (no)
IL (1) IL124356A (no)
MX (1) MX9803918A (no)
NO (1) NO316869B1 (no)
NZ (1) NZ324674A (no)
PL (1) PL186915B1 (no)
RO (1) RO117589B1 (no)
RU (1) RU2166939C2 (no)
TR (1) TR199801126T2 (no)
TW (1) TW430561B (no)
WO (1) WO1997022340A1 (no)
ZA (1) ZA9610714B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802973D0 (sv) 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US6599530B2 (en) * 1998-09-14 2003-07-29 Orion Corporation Oral compacted composition comprising catechol derivatives
US6660303B2 (en) * 1999-12-06 2003-12-09 Edward Mendell & Co. Pharmaceutical superdisintegrant
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
WO2005028621A2 (en) * 2003-09-15 2005-03-31 Vitra Bioscience, Inc. Assays with primary cells
WO2007112098A2 (en) * 2006-03-24 2007-10-04 The Texas A & M University System And Safe Et Al Uses of diphenyl/diphenylamine carboxylic acids
TWI405574B (zh) * 2007-06-21 2013-08-21 Otsuka Pharma Co Ltd 藥學固體製劑及其製造方法
US8367427B2 (en) * 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
CA3036053A1 (en) * 2016-09-07 2018-03-15 Celgene Corporation Tablet compositions
CN111184707B (zh) * 2020-02-20 2021-04-27 中山大学 托芬那酸或其药学上可接受的盐在制备预防和/或治疗新型冠状病毒炎症药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE116061C (no) *
FI89004C (fi) * 1988-02-16 1993-08-10 Pertti J Neuvonen Anvaendning av tillsatsmedel foer oekning av absorptionshastigheten av laekemedel i orala laekemedelspreparat
IT1276689B1 (it) * 1995-06-09 1997-11-03 Applied Pharma Res Forma farmaceutica solida ad uso orale

Also Published As

Publication number Publication date
PL327584A1 (en) 1998-12-21
AU1190097A (en) 1997-07-14
AR004395A1 (es) 1998-11-04
CZ194398A3 (cs) 1998-11-11
TR199801126T2 (xx) 1998-08-21
HU224030B1 (hu) 2005-05-30
IL124356A0 (en) 1998-12-06
IL124356A (en) 2001-05-20
ATE234085T1 (de) 2003-03-15
NO316869B1 (no) 2004-06-07
EP0869783A1 (en) 1998-10-14
CN1208345A (zh) 1999-02-17
PL186915B1 (pl) 2004-03-31
HUP9903410A3 (en) 2000-05-29
ES2191781T3 (es) 2003-09-16
JP2000515489A (ja) 2000-11-21
CA2244396A1 (en) 1997-06-26
BR9612057A (pt) 1999-02-23
DE69626676T2 (de) 2003-12-18
NZ324674A (en) 2000-01-28
HUP9903410A2 (hu) 2000-04-28
RO117589B1 (ro) 2002-05-30
NO982875D0 (no) 1998-06-19
CN1147295C (zh) 2004-04-28
RU2166939C2 (ru) 2001-05-20
WO1997022340A1 (en) 1997-06-26
EE9800186A (et) 1998-12-15
HRP960598A2 (en) 1998-02-28
MX9803918A (es) 1998-09-30
EP0869783B1 (en) 2003-03-12
DE69626676D1 (de) 2003-04-17
US6036975A (en) 2000-03-14
ZA9610714B (en) 1997-06-30
CZ293422B6 (cs) 2004-04-14
TW430561B (en) 2001-04-21
DK0869783T3 (da) 2003-06-02

Similar Documents

Publication Publication Date Title
NO2018014I2 (no) Deferasirox eller et farmasøytisk akseptabelt salt derav
NO2009028I2 (no) Gefitinib eller et farmasøytisk akseptabelt salt derav
DE69529598D1 (de) Arzneimittelenthaltende Manschette
IL111380A0 (en) Potentiation of drug response
FI973002A0 (fi) Terapeuttinen yhdiste - rasvahappokonjugaatit
FI973243A0 (fi) Uusi farmaseuttinen yhdistelmä
DE59608081D1 (de) Transcorneales arzneimittelfreigabesystem
NO20040145L (no) Anvendelse av benzensulfonamidderivater for fremstilling av et medikament
NO2010003I2 (no) Prukaloprid eller et farmasøytisk aksepterbart syreaddisjonssalt derav
BR9610396A (pt) Formulação farmacêutica
FI954007A (fi) Substituoitujen 4-fenyyli-6-amino-nikotiinihappojohdannaisten käyttö lääkeaineena
NO963430L (no) Hurtig nedbrytbar medikamentform av tramadol eller et tramadolsalt
NO982875L (no) Tablett med hurtig frigivelse omfattende tolfenaminsyre eller et farmasöytisk akseptabelt salt av denne
NO173239C (no) Analogifremgangsmaate til fremstilling av et terapeutisk aktivt etopodofyllotoksinglukosidacylderivat
NO973610D0 (no) Nytt farmasöytisk preparat
IL118299A (en) Use of AII-receptor antagonists for the manufacture of a medicament with effect on multiple system organ failure
EE03384B1 (et) Melatoniini kasutamine ravimi tootmiseks
FI973230A (fi) Uusi farmaseuttinen formulaatio
DE69632787D1 (de) Pharmazeutische pellets
NO20003393L (no) FremgangsmÕte for fremstilling av en farmasøytisk formulering
ZA948357B (en) Potentiation of drug response
BR9603673A (pt) Preparado de combinação farmacêutica compreendendo cetoprofeno
KR970003938U (ko) 환자 보조용 헬멧
UA1292S (uk) Таблетка фармацевтична
KR950003053U (ko) 사우나 부스용 한약제 찜통

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees